Capital raised by Myrtelle
2 Form D filings · first filed Mar 2025 · New York, NY
Chief Executive Officer and Director
Signatory on Myrtelle's Form D filings · $24.2M raised across 2
Adiran Stecyk is on file as Chief Executive Officer and Director at Myrtelle in New York, NY. Myrtelle has 2 Form D filings on record, $24.2M raised in total. Adiran Stecyk appears as a signatory on the company's filings.
rAAV-Olig001-ASPA is an investigational gene therapy specifically designed to treat Canavan disease, a severe childhood genetic disorder characterized by the degeneration of white matter in the brain.
